KALA BIO
KALA
63 hedge funds and large institutions have $149M invested in KALA BIO in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 25 increasing their positions, 12 reducing their positions, and 9 closing their positions.
108% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 12
1.05% less ownership
Funds ownership: 69.94% → 68.89% (-1%)
7% less funds holding
Funds holding: 68 → 63 (-5)
24% less capital invested
Capital invested by funds: $196M → $149M (-$47.2M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
96% less call options, than puts
Call options by funds: $19K | Put options by funds: $530K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.89M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.66M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.28M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.06M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
+$1.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.58M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$2.48M |
| 3 |
GX
Greylock XII
Menlo Park,
California
|
-$1.65M |
| 4 |
Millennium Management
New York
|
-$1.56M |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
-$547K |
KALA Hedge Fund Activity: Q2 2019 in Review
63 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q2 2019, worth a combined $149M — down 24% from $196M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of KALA and 6 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 25 added.
The largest buyer was BlackRock, adding an estimated $1.89M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $2.58M sold.
- 63 institutional investors held KALA BIO (KALA) as of Q2 2019, down from 68 in Q1 2019.
- Funds reported $149M of KALA BIO stock for Q2 2019, down 24% quarter-over-quarter.
- 6 funds opened new KALA BIO positions in Q2 2019 and 9 closed out, a net change of -3 holders.
- The largest KALA BIO buyer in Q2 2019 was BlackRock, an estimated $1.89M added.
- The largest KALA BIO seller in Q2 2019 was Point72 Asset Management, an estimated $2.58M sold.
Based on aggregated 13F filings for Q2 2019.